Prof. MEHMET ALİ AĞIRBAŞLI

Biography

Currently a professor of cardiology at Medeniyet University Medical School in Istanbul. He has held a faculty appointment at Marmara University between 2003- 15. He is a fellow of the American College of Cardiology (FACC).
Prior to his research and independent academic work in Turkey,  he was a faculty at the Division of Cardiology, Vanderbilt University Medical School in Nashville, USA (2002-03). He has been trained as a researcher under the mentorship of Dr Douglas E Vaughan at Vanderbilt University focusing on fibrinolytic balance and thrombotic risk factors. In addition, he completed an interventional cardiology fellowship at Emory University in Atlanta between 1998-99, cardiology fellowship at Vanderbilt University (1995-98) and coursework in genetics at the Jackson Laboratory in Maine. He graduated as a specialist in internal medicine following postgraduate training at the State University of New York (1992-95). He holds a MD degree from the Hacettepe University Medical School in Ankara (1991). He worked as a researcher at the Bogalusa Heart Study on cardiovascular risk factors in children with Dr Gerald S Berenson at Tulane University. He currently maintains an active collaboration in the same study. His current research focuses on novel cardiovascular risk factors particularly as they relate to plasmogen activator inhibitor system. He is a former Associate Editor for the Archives of Turkish Society of Cardiology (2004-2010), and serves as an editorial board member and/or peer reviewer for Current Pharmacogenomics and Personalized Medicine, OMICS: Journal of Integrative Biology, Clinical and Applied Thrombosis.
In 2009, his research together with Professor Gönenc Ciliv (Hacettepe University, Ankara) was recognized by the Sedat Simavi Foundation for “Metabolic Syndrome in Turkish Children”.
He is ABIM certified in internal medicine, cardiology, interventional cardiology and heart failure and transplant medicine.